HCA Healthcare, Inc. is set to showcase its financial strength at several key healthcare conferences in March 2026, following a quarterly revenue increase to $19.51 billion and a strong EPS of $8.01. Despite a slight revenue miss against estimates, HCA outperformed EPS expectations and is ranked No. 1 in its industry, recognized on Fortune’s Most Admired Companies list. With ambitious forecasts of $76.5 billion to $80 billion in annual revenues, the company is also expanding its U.S. presence through new emergency facilities in Florida.
“HCA Healthcare, Inc. · is scheduled to present at · TD Cowen Health Care Conference · March 3, 2026 at 10:30am ET”
“HCA Healthcare, Inc. · is scheduled to present at · Raymond James Institutional Investors Conference · March 4, 2026 at 9:50am ET”
“HCA Healthcare, Inc. · is scheduled to present at · Leerink Partners Global Healthcare Conference · March 10, 2026 at 10:00am ET”
“HCA Healthcare, Inc. · is scheduled to present at · Barclays Global Healthcare Conference · March 10, 2026 at 2:00pm ET”
“HCA Healthcare, Inc. · is scheduled to present at · Oppenheimer MedTech & Services Conference · March 16, 2026 at 3:20pm ET”
“HCA Healthcare, Inc. · is scheduled to present at · KeyBanc Healthcare Forum · March 17, 2026 at 3:00pm ET”
“HCA Healthcare · reported revenues · $19.51 billion · in the last reported quarter”
“HCA Healthcare's EPS · for the same period was · $8.01 · compared to $6.22 a year ago”
“HCA Healthcare · has been named on · Fortune’s 2026 World’s Most Admired Companies list · true”
“HCA Healthcare · is ranked · No. 1 in its industry · true”
“HCA Healthcare · reported · fourth-quarter adjusted earnings per share (EPS) · $8.01”
“HCA Healthcare · outpaced · Zacks Consensus Estimate · 8.8%”
